Evidence map›Paper›PMID 39409956›Full record

ArticleCancers2024

Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus.

Kori Leblanc, Scott J Edwards, George Dranitsaris, Darryl P Leong, Marc Carrier, Shawn Malone, Ricardo A Rendon, Alison M Bond, Troy D Sitland, Pawel Zalewski and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Navigating drug-drug interactions with apalutamide.Prostate cancer and prostatic diseases · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kori LeblancDepartment of Pharmacy, University Health Network, Toronto, ON M5G 2C4, Canada.ORCID 0000-0002-9996-0663
Scott J EdwardsCancer Care Program, Eastern Health, St. John's, NL A1B 3V6, Canada.
George DranitsarisDepartment of Public Health, Falk College, Syracuse University, Syracuse, NY 13244, USA.
Darryl P LeongHamilton Health Sciences, Population Health Research Institute, Hamilton, ON L8L 2X2, Canada.ORCID 0000-0002-1968-169X
Marc CarrierThe Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada.ORCID 0000-0001-8296-2972
Shawn MaloneThe Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Ricardo A RendonQueen Elizabeth II Health Sciences Centre, Halifax, NS B3H 3A7, Canada.
Alison M BondSunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.
Troy D SitlandDepartment of Urology, Dalhousie University, Halifax, NS B3H 1Y6, Canada.
Pawel ZalewskiDurham Regional Cancer Centre, Oshawa, ON L1G 2B9, Canada.
Michelle WangBayer Inc., Mississauga, ON L4W 5R6, Canada.
Urban EmmeneggerOdette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.ORCID 0000-0002-3178-1896

Funding

Bayer (Canada) N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

androgen receptor axis-target therapyanticoagulantdrug–drug interactionsprostate cancerthrombosis

Identifiers

PMID39409956
PMCPMC11475820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.